A Study to Compare the Efficacy of Sirolimus-Eluting Stents With Biodegradable Polymer Versus Zotarolimus-Eluting Stents With Durable Polymer in Patients with Coronary Artery Disease (CAD) who Underwent Percutaneous Coronary Intervention (PCI)

Trial Profile

A Study to Compare the Efficacy of Sirolimus-Eluting Stents With Biodegradable Polymer Versus Zotarolimus-Eluting Stents With Durable Polymer in Patients with Coronary Artery Disease (CAD) who Underwent Percutaneous Coronary Intervention (PCI)

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Dec 2015

At a glance

  • Drugs Sirolimus (Primary) ; Zotarolimus (Primary)
  • Indications Coronary artery disease
  • Focus Therapeutic Use
  • Acronyms ALSTER-OCT
  • Most Recent Events

    • 28 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top